Braxia Scientific Corp (BRAXF)
0.0065
0.00 (0.00%)
USD |
OTCM |
Jun 24, 16:00
Braxia Scientific Total Assets (Quarterly): 1.763M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.763M |
| September 30, 2023 | 2.142M |
| June 30, 2023 | 2.043M |
| March 31, 2023 | 2.872M |
| December 31, 2022 | 6.922M |
| September 30, 2022 | 10.06M |
| June 30, 2022 | 8.394M |
| March 31, 2022 | 9.319M |
| December 31, 2021 | 12.11M |
| Date | Value |
|---|---|
| September 30, 2021 | 13.24M |
| June 30, 2021 | 14.15M |
| March 31, 2021 | 14.65M |
| December 31, 2020 | 15.76M |
| September 30, 2020 | 15.74M |
| June 30, 2020 | 16.47M |
| March 31, 2020 | 9.920M |
| December 31, 2019 | 0.7806M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.7806M
Minimum
Dec 2019
16.47M
Maximum
Jun 2020
9.196M
Average
9.920M
Median
Mar 2020
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 73.30M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 6.475M |
| Lexaria Bioscience Corp | 6.352M |
| Xenon Pharmaceuticals Inc | 919.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.038M |
| Shareholders Equity (Quarterly) | -0.2758M |
| Debt to Equity Ratio | -0.2955 |
| Current Ratio | 0.1802 |
| Net Debt Paydown Yield | 6.85% |